|
⚲
|
| Keyboard |
| Li Dean Y
✚
|
|
|---|---|
| CIK # | 0001837016 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001837016] | |
| 4 | [0001837016] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Li Dean Y | |
| Recursion Pharmaceuticals Inc | |
| Merck & Co Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merck & Co Inc MRK
Common Stock
|
2026-02-10 | Sell | 10,235 | $117.52 | 1,202,817 |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2026-02-04 | Option exercise | 15,087 | $0.00 | |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-04 | Option exercise | 15,087 | $56.04 | 845,475 |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-04 | Sell | 15,087 | $118.77 | 1,791,883 |
|
Merck & Co Inc MRK
Common Stock
|
2026-01-26 | Grant | 20,469 | $107.40 | 2,198,371 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-01-02 | Grant | 2,381 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-10-01 | Grant | 1,961 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-07-01 | Grant | 1,949 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 44,031 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-06-18 | Grant | 22,016 | $0.00 | |
|
Merck & Co Inc MRK
Restricted Stock Unit · derivative
|
2025-04-29 | Grant | 14,166 | $0.00 | |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 64,481 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-04-01 | Grant | 2,268 | $0.00 | |
|
Merck & Co Inc MRK
Common Stock
|
2025-01-27 | Grant | 32,621 | $97.94 | 3,194,901 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-01-02 | Grant | 1,647 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-10-01 | Grant | 1,925 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-07-01 | Grant | 1,592 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-06-03 | Grant | 13,097 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2024-06-03 | Grant | 26,193 | $0.00 | |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2024-04-30 | Grant | 65,625 | $0.00 | |
| showing 20 of 88 most recent transactions | |||||